Analystreport

Corvus Pharmaceuticals Inc (NASDAQ: CRVS) is now covered by analysts at Jefferies Group LLC. They set a "buy" rating on the stock.

Corvus Pharmaceuticals, Inc.  (CRVS) 
Last corvus pharmaceuticals, inc. earnings: 4/30 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: corvuspharma.com